ArticleScientific reports2024

Exploring optimal drug targets through subtractive proteomics analysis and pangenomic insights for tailored drug design in tuberculosis.

Muhammad Fayaz Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.